Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms.

Leukemia research - 1 Jan 2008

Maggini Valentina, Buda Gabriele, Galimberti Sara, Conidi Elena, Giuliani Nicola, Morabito Fortunato, Genestreti Giovenzio, Iacopino Pasquale, Rizzoli Vittorio, Barale Roberto, Petrini Mario, Rossi Anna Maria

Abstract excerpt

This study examines the response to dexamethasone-doxorubicin-vincristine (DAV) therapy, followed by conditioning regimen and autologous stem cells transplantation (ASCT) in patients with multiple myeloma in relation with the presence of polymorphisms in genes involved in drug metabolism (GSTP1)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclophosphamide
Share to Dacarbazine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melphalan

Share to Stem Cell Transplantation

Share to Thymidylate Synthase

Share to Transplantation, Autologous

Share to Transplantation Conditioning

Share to Vincristine

Source

Identifiers

PMID: 17512053
DOI: 10.1016/j.leukres.2007.03.029

Genes

TYMS
GSTP1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17512053-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms.PMID 17512053Read ↗

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide.Semantic proximity Read ↗

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.Semantic proximity Read ↗

GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis.Semantic proximity Read ↗

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple MyelomaSemantic proximity Read ↗

Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.Semantic proximity Read ↗

Glutathione S-transferase polymorphisms in osteosarcoma patients.Semantic proximity Read ↗

Polymorphisms of glutathione S-transferase mu1 (GSTM1) and theta1 (GSTT1) genes in multiple myeloma.Semantic proximity Read ↗

Genetic predisposition and treatment-related leukemia.Semantic proximity Read ↗

Polymorphisms contribution to the determination of significant risk of specific toxicities in multiple myeloma.Semantic proximity Read ↗

Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients.Semantic proximity Read ↗

MDR1 diplotypes as prognostic markers in multiple myeloma.Semantic proximity Read ↗

Influence of glutathione S‐transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment responseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.